“…23,[72][73] A substantial proportion (33-54%) of BMT survivors experience significant psychological and emotional distress, such as mood disturbance, tension, and depression after completion of treatment. 16,18,74 High prevalence rates (45-65%) of anxiety and depression have been reported by breast cancer, BMT, colorectal, prostate, and lung cancer survivors. 23 Long-term survivors of pediatric leukemia, Hodgkin disease, and non-Hodgkin lymphoma were more likely to report symptoms of depression and somatic distress than their sibling controls, and having high dose chemotherapy contributed to the risk of developing these symptoms.…”